Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Seven-Year Follow-up of Gene Therapy for Leber's Hereditary Optic Neuropathy.

Ophthalmology - 1 Aug 2020

Yuan Jiajia, Zhang Yong, Liu Hongli, Wang Dan, Du Yangyang, Tian Zhen, Li Xin, Yang Shuo, Pei Han, Wan Xing, Xiao Su, Song Lin, Xiao Xiao, Sun Jian, Wang Zhitao, Li Bin

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Mitochondrial
Share to DNA Mutational Analysis
Share to Follow-Up Studies
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to NADH Dehydrogenase

Share to Optic Atrophy, Hereditary, Leber

Share to Time Factors

Share to Visual Acuity

Source

Identifiers

PMID: 32284191
DOI: 10.1016/j.ophtha.2020.02.023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Seven-Year Follow-up of Gene Therapy for Leber's Hereditary Optic Neuropathy.PMID 32284191Read ↗

Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy.Semantic proximity Read ↗

Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy.Semantic proximity Read ↗

The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy.Semantic proximity Read ↗

Leber Hereditary Optic Neuropathy Gene Therapy: Adverse Events and Visual Acuity Results of All Patient GroupsSemantic proximity Read ↗

Ethambutol-induced conversion in Leber's hereditary optic neuropathy: 6 years follow-up.Semantic proximity Read ↗

Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset.Semantic proximity Read ↗

Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial RecruitmentSemantic proximity Read ↗

Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study.Semantic proximity Read ↗

Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic NeuropathySemantic proximity Read ↗

How long does gene therapy last? 4-year follow-up of phase 3 voretigene neparvovec trial in RPE65-associated LCA/inherited retinal diseaseSemantic proximity Read ↗

Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.Semantic proximity Read ↗

[Clinical research progress of gene therapy for Leber hereditary optic neuropathy].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.